Their session titled: “Canada & CETA: The times they are a changin’” will provide an important and timely update on the Canadian patent law landscape and provide insights on the impact of CETA and Bill C-30 to pharmaceutical companies operating in Canada.
Find out more about the conference here.
|Yoon Kang||David Schwartz|
Smart & Biggar is Canada's largest firm practising exclusively in intellectual property and technology law, with offices in Ottawa, Toronto, Montreal, Vancouver and Calgary. We are leaders in intellectual property and technology law and have been serving clients for over a century. For more information, please visit smart-biggar.ca.